122 related articles for article (PubMed ID: 37782060)
21. Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma.
de Jong RA; Kema IP; Boerma A; Boezen HM; van der Want JJ; Gooden MJ; Hollema H; Nijman HW
Gynecol Oncol; 2012 Sep; 126(3):474-80. PubMed ID: 22668882
[TBL] [Abstract][Full Text] [Related]
22. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract][Full Text] [Related]
23. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
[TBL] [Abstract][Full Text] [Related]
24. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.
Wainwright DA; Balyasnikova IV; Chang AL; Ahmed AU; Moon KS; Auffinger B; Tobias AL; Han Y; Lesniak MS
Clin Cancer Res; 2012 Nov; 18(22):6110-21. PubMed ID: 22932670
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
[TBL] [Abstract][Full Text] [Related]
26. Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy.
Zahm CD; Johnson LE; McNeel DG
Cancer Immunol Immunother; 2019 Oct; 68(10):1661-1669. PubMed ID: 31606777
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer.
Nishi M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Ishikawa D; Wada Y; Shimada M
Anticancer Res; 2018 Jun; 38(6):3387-3392. PubMed ID: 29848687
[TBL] [Abstract][Full Text] [Related]
28. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
Sun S; Du G; Xue J; Ma J; Ge M; Wang H; Tian J
Int J Immunopathol Pharmacol; 2018; 32():2058738418787991. PubMed ID: 29993291
[TBL] [Abstract][Full Text] [Related]
29. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
[TBL] [Abstract][Full Text] [Related]
30. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.
Mangaonkar A; Mondal AK; Fulzule S; Pundkar C; Park EJ; Jillella A; Kota V; Xu H; Savage NM; Shi H; Munn D; Kolhe R
Sci Rep; 2017 Oct; 7(1):12892. PubMed ID: 29038460
[TBL] [Abstract][Full Text] [Related]
31. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of indoleamine-2,3-dioxygenase and the receptors for transforming growth factor β and interferon γ in metastatic lymph nodes in malignant melanoma.
Pelak MJ; Śnietura M; Lange D; Nikiel B; Pecka KM
Pol J Pathol; 2015 Dec; 66(4):376-82. PubMed ID: 27003769
[TBL] [Abstract][Full Text] [Related]
33. FoxP3 and IDO in Canine Melanocytic Tumors.
Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
[TBL] [Abstract][Full Text] [Related]
34. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
35. Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.
Asghar K; Loya A; Rana IA; Abu Bakar M; Farooq A; Tahseen M; Ishaq M; Rashid MU
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3521-3525. PubMed ID: 31759380
[TBL] [Abstract][Full Text] [Related]
36. Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.
Mandarano M; Bellezza G; Belladonna ML; Van den Eynde BJ; Chiari R; Vannucci J; Mondanelli G; Ludovini V; Ferri I; Bianconi F; Del Sordo R; Cagini L; Albini E; Metro G; Puma F; Sidoni A
Virchows Arch; 2019 Feb; 474(2):159-168. PubMed ID: 30448912
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma.
Wang L; Ma Q; Li D; Mu S; Li Y; Wang Y; Shi P; Yu H; Gao C; Guo K; Zhang Z
Pathol Res Pract; 2018 Sep; 214(9):1309-1314. PubMed ID: 30029936
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma.
Pan K; Wang H; Chen MS; Zhang HK; Weng DS; Zhou J; Huang W; Li JJ; Song HF; Xia JC
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1247-53. PubMed ID: 18438685
[TBL] [Abstract][Full Text] [Related]
39. Association between endometrial indoleamine 2,3-dioxygenase expression level and pregnancy outcomes in women undergoing first in vitro fertilization treatment.
Liu S; Hong L; Li Y; Lian R; Wang X; Zeng Y
BMC Pregnancy Childbirth; 2021 Jan; 21(1):33. PubMed ID: 33413226
[TBL] [Abstract][Full Text] [Related]
40. [Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer].
Sakurai K; Fujisaki S; Nagashima S; Shibata M; Maeda T; Ueda Y; Hara Y; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1927-9. PubMed ID: 22202241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]